AEE788 T2116
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.
CAS nr:
497839-62-0
Purity:
98%
Molecular Weight:
440,58
SMILES:
c1nc2c(c(n1)N[C@H](C)c1ccccc1)cc([nH]2)c1ccc(cc1)CN1CCN(CC1)CC
Formula:
C27H32N6
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling,Apoptosis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling
Target:
FLT,FLT,EGFR,EGFR,EGFR,Apoptosis,c-Fms,Bcr-Abl,Bcr-Abl,Bcr-Abl
